Analysis Henry Schein, Inc. (0L3C)
5/27/2024
Analysis of Henry Schein, Inc. (0L3C)
Henry Schein, Inc. is a company that provides health care products and services to medical, dental, and veterinary office-based practitioners. Looking at the recent data, we can see that the stock price has been fluctuating around the $72-$74 range in the past week.The Relative Strength Index (RSI) indicator has been hovering around 50, indicating a neutral sentiment in the market. The Moving Average Convergence Divergence (MACD) indicator has shown positive momentum, with the MACD line crossing above the signal line, suggesting a potential bullish trend.
Overall, based on the technical indicators, it seems that Henry Schein, Inc. may experience some upward movement in the near future. However, it is important to consider other factors such as market conditions and company news before making any investment decisions.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not supplied at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.
Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.18 and price-to-sales ratio of 7.62. The stock has an enterprise-to-EBITDA ratio of 22.75 and an enterprise-to-revenue ratio of 7.73.
The stock price summary includes a beta of 1.26, a 50-day moving average of $173.69, and a 200-day moving average of $180.79. The stock's 52-week low is $164.08, the high is $199.62, and the change over the 52 weeks is 8.25%.
Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The stock had a 4-for-1 split on August 31, 2020. The 5-year average dividend yield is 0.73% and the trailing annual dividend yield is 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent growth in sales from FY 2020 to FY 2022.
- Overall, there has been a significant increase in sales over the four-year period, indicating positive growth in the company's revenue.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts' forecasts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This forecast is based on the input of 39 analysts.
Overall, the analysts are predicting growth in earnings per share both for the upcoming quarters and the next fiscal years, indicating positive expectations for the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates indicate a generally positive outlook for the company, with expected growth in both quarterly and annual sales over the coming periods.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical performance. However, the company is still projected to experience double-digit growth over the next 5 years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it can be observed that the analysts have a range of opinions regarding the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, indicating a potential upside according to the analysts' predictions.
MACD of 0L3C
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
